Bakhos Tannous, Executive Director, Head of Rare Cancer Discovery at AstraZeneca and Alexion Pharmaceuticals, shared a post on LinkedIn:
“I’m happy to share that I’ve started a new position as Executive Director, Head of Rare Cancer Discovery at AstraZeneca and Alexion Pharmaceuticals, Inc.!
I’m incredibly excited to lead efforts across discovery and clinical strategy to bring new therapies for patients with rare cancers—an area where the need is great and the impact can be life-changing.
It’s an honor to join a team so dedicated to advancing science and making a real difference for patients who often have limited treatment options.
Looking forward to what’s ahead!”
More posts featuring AstraZeneca.